Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees

Gillard

Chris Gillard, Victoria AU

Patent application numberDescriptionPublished
20110156988DISPLAY FOR AN IMAGE - A display for an image including: a first substrate having a cyan layer of the image thereon; a second substrate having a magenta layer of the image thereon; a third substrate having a yellow layer of the image thereon; a fourth substrate having a black layer of the image thereon; the substrate layers being aligned thereby displaying the complete image.06-30-2011

Corinne Gillard, Gressy En France FR

Patent application numberDescriptionPublished
20080248526Recombinant Cell Lines for the Stable and High-Level Production of Biologically Active Dkk1 Protein - This invention relates to the use of specific recombinant cell lines in order to produce biologically active DKK1 protein in a stable and high-level manner. The invention also relates to these recombinant cell lines, as well as a method for stable and high-level production of biologically active DKK1 protein, implementing such recombinant cell lines.10-09-2008

Grant L. Gillard, Burlington CA

Patent application numberDescriptionPublished
20090255095BREAKAWAY LANYARD AND HARDWARE FOR MAKING SAME - Amongst other things, there is disclosed a breakaway lanyard comprising a carrier body having an upper end and an opposed lower end, and a lanyard strap having a first end and a second end. The first end is releasably connectable to the carrier body. The second end is fixed to the carrier body substantially at the upper end thereof. The first end is releasable from connection with the body portion upon application to the lanyard strap of a force exceeding a threshold level of force.10-15-2009

James Gillard, Laval CA

Patent application numberDescriptionPublished
20090087409Viral Polymerase Inhibitors - An isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula I:04-02-2009

James Gillard, Rosemère CA

Patent application numberDescriptionPublished
20120101091VIRAL POLYMERASE INHIBITORS - The present application provides compounds of formula I wherein X, Y, R04-26-2012

John Gillard, Baie D'Urfe CA

Patent application numberDescriptionPublished
20080293653Method of treating autoimmune diseases - The invention features a method of inducing an apoptosis-resistant cell to undergo apoptosis, in which the cell is associated with an autoimmune disease such as multiple sclerosis. The method involves sensitizing the cell to apoptosis stimuli by treating the cell with an IAP antisense oligonucleotide, so that the cell undergoes apoptosis at a site of autoimmune disease.11-27-2008
20100203012IAP BIR DOMAIN BINDING COMPOUNDS - Disclosed herein is a compound of Formula 1:08-12-2010
20110136133METHOD FOR DIFFERENTIATING BETWEEN MULTIPLE SCLEROSIS SUBTYPES - Disclosed herein is a method for differentiating between multiple sclerosis subtypes in a patient. The method comprises a) determining an amount of an IAP gene expression level in a blood sample obtained from the patient; and b) correlating the amount of the IAP gene expression level in the blood sample with the presence of a multiple sclerosis subtype in the patient.06-09-2011

Patent applications by John Gillard, Baie D'Urfe CA

John W. Gillard, Baie D'Urfe CA

Patent application numberDescriptionPublished
20080207525IAP BIR domain binding compounds - Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I or II08-28-2008
20090042953IMIDAZO [2,1,-b]-1,3,4-THIADIAZOLE SULFONAMIDES - This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems. Formula I:02-12-2009
20100221261IAP BIR DOMAIN BINDING COMPOUNDS - Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I or II09-02-2010

Patent applications by John W. Gillard, Baie D'Urfe CA